{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:47:18Z","timestamp":1792025238010,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lin\u2019an Sci-Tech Guidance Project","award":["2023Y07"],"award-info":[{"award-number":["2023Y07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-05446-3","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:44:13Z","timestamp":1791827053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sustained potassium control and recurrent hyperkalemia during individualized potassium-guided sodium zirconium cyclosilicate titration in maintenance hemodialysis: a post hoc analysis of a randomized trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Haiming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8798-7558","authenticated-orcid":false,"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"5446_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-026-05286-y","author":"Y Jiang","year":"2026","unstructured":"Jiang Y, Fang Y, Gong F, et al. Efficacy and safety of sodium zirconium cyclosilicate on non-dialysis days for long-term management of chronic hyperkalemia in maintenance hemodialysis: a single-center, prospective, open-label, randomized controlled trial. Int Urol Nephrol. 2026. https:\/\/doi.org\/10.1007\/s11255-026-05286-y.","journal-title":"Int Urol Nephrol"},{"issue":"6","key":"5446_CR2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ekir.2020.02.1028","volume":"5","author":"S Bansal","year":"2020","unstructured":"Bansal S, Pergola PE. Current management of hyperkalemia in patients on dialysis. Kidney Int Rep. 2020;5(6):779\u201389. https:\/\/doi.org\/10.1016\/j.ekir.2020.02.1028.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"5446_CR3","doi-asserted-by":"publisher","first-page":"2384585","DOI":"10.1080\/0886022X.2024.2384585","volume":"46","author":"H Jin","year":"2024","unstructured":"Jin H, Lu R, Zhang L, et al. Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K). Ren Fail. 2024;46(2):2384585. https:\/\/doi.org\/10.1080\/0886022X.2024.2384585.","journal-title":"Ren Fail"},{"issue":"7","key":"5446_CR4","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/ckj\/sfaa208","volume":"14","author":"A Karaboyas","year":"2021","unstructured":"Karaboyas A, Robinson BM, James G, et al. Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patients. Clin Kidney J. 2021;14(7):1760\u20139. https:\/\/doi.org\/10.1093\/ckj\/sfaa208.","journal-title":"Clin Kidney J"},{"issue":"1","key":"5446_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/0886022X.2020.1871012","volume":"43","author":"D Bem","year":"2021","unstructured":"Bem D, Sugrue D, Wilding B, et al. The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review. Ren Fail. 2021;43(1):241\u201354. https:\/\/doi.org\/10.1080\/0886022X.2020.1871012.","journal-title":"Ren Fail"},{"issue":"1","key":"5446_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.ajkd.2016.10.024","volume":"70","author":"SM Brunelli","year":"2017","unstructured":"Brunelli SM, Du Mond C, Oestreicher N, et al. Serum potassium and short-term clinical outcomes among hemodialysis patients: impact of the long interdialytic interval. Am J Kidney Dis. 2017;70(1):21\u20139. https:\/\/doi.org\/10.1053\/j.ajkd.2016.10.024.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5446_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","volume":"97","author":"CM Clase","year":"2020","unstructured":"Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020;97(1):42\u201361. https:\/\/doi.org\/10.1016\/j.kint.2019.09.018.","journal-title":"Kidney Int"},{"issue":"9","key":"5446_CR8","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1681\/ASN.2019050450","volume":"30","author":"S Fishbane","year":"2019","unstructured":"Fishbane S, Ford M, Fukagawa M, et al. A phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia. J Am Soc Nephrol. 2019;30(9):1723\u201333. https:\/\/doi.org\/10.1681\/ASN.2019050450.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5446_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12882-021-02569-7","volume":"23","author":"S Fishbane","year":"2022","unstructured":"Fishbane S, Ford M, Fukagawa M, et al. Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE. BMC Nephrol. 2022;23(1):59. https:\/\/doi.org\/10.1186\/s12882-021-02569-7.","journal-title":"BMC Nephrol"},{"issue":"12","key":"5446_CR10","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1016\/j.ekir.2021.09.004","volume":"6","author":"M Ford","year":"2021","unstructured":"Ford M, Fishbane S, Spinowitz B, et al. Effectiveness of sodium zirconium cyclosilicate in hemodialysis patients with severe hyperkalemia. Kidney Int Rep. 2021;6(12):3074\u20138. https:\/\/doi.org\/10.1016\/j.ekir.2021.09.004.","journal-title":"Kidney Int Rep"},{"issue":"7","key":"5446_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.clinthera.2023.04.014","volume":"45","author":"Z Ni","year":"2023","unstructured":"Ni Z, Lu R, Xu X, et al. DIALIZE China: a phase IIIb, randomized, placebo-controlled study to reduce predialysis hyperkalemia with sodium zirconium cyclosilicate in Chinese patients. Clin Ther. 2023;45(7):633\u201342. https:\/\/doi.org\/10.1016\/j.clinthera.2023.04.014.","journal-title":"Clin Ther"},{"issue":"11","key":"5446_CR12","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1016\/j.ekir.2024.08.005","volume":"9","author":"JP Middleton","year":"2024","unstructured":"Middleton JP, Sun S, Murray S, et al. Randomized trial of patiromer on efficacy to reduce episodic hyperkalemia in patients with ESKD treated with hemodialysis. Kidney Int Rep. 2024;9(11):3218\u201325. https:\/\/doi.org\/10.1016\/j.ekir.2024.08.005.","journal-title":"Kidney Int Rep"},{"issue":"7","key":"5446_CR13","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136. https:\/\/doi.org\/10.1093\/aje\/kwh090.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"5446_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/hdi.12983","volume":"26","author":"BS Spinowitz","year":"2022","unstructured":"Spinowitz BS, McCafferty K, Fishbane S, et al. Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients. Hemodial Int. 2022;26(2):274\u20137. https:\/\/doi.org\/10.1111\/hdi.12983.","journal-title":"Hemodial Int"},{"issue":"6","key":"5446_CR15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.2215\/CJN.12651018","volume":"14","author":"BS Spinowitz","year":"2019","unstructured":"Spinowitz BS, Fishbane S, Pergola PE, et al. Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 study. Clin J Am Soc Nephrol. 2019;14(6):798\u2013809. https:\/\/doi.org\/10.2215\/CJN.12651018.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"5446_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.kint.2025.06.016","volume":"108","author":"S Fishbane","year":"2025","unstructured":"Fishbane S, Dember LM, Jadoul M, et al. The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis. Kidney Int. 2025;108(4):686\u201394. https:\/\/doi.org\/10.1016\/j.kint.2025.06.016.","journal-title":"Kidney Int"},{"issue":"1","key":"5446_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.kint.2024.10.010","volume":"107","author":"DM Charytan","year":"2025","unstructured":"Charytan DM, Winkelmayer WC, Granger CB, et al. Effects of dialysate potassium concentration of 3.0 mmol\/L with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol\/L alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia. Kidney Int. 2025;107(1):169\u201379. https:\/\/doi.org\/10.1016\/j.kint.2024.10.010.","journal-title":"Kidney Int"},{"issue":"2","key":"5446_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.ajkd.2016.09.015","volume":"69","author":"A Karaboyas","year":"2017","unstructured":"Karaboyas A, Zee J, Brunelli SM, et al. Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017;69(2):266\u201377. https:\/\/doi.org\/10.1053\/j.ajkd.2016.09.015.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05446-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05446-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05446-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:11:58Z","timestamp":1792023118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05446-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5446"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05446-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"1 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The parent trial was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of The First People\u2019s Hospital of Lin\u2019an District (approval No. 2023-27). All participants provided written informed consent before enrollment. The present analysis used de-identified data collected under the approved protocol and involved no additional intervention or data collection.00","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"612"}}